30 Apr 2025
Ambuja Cements
BOB Capital Markets Ltd.
Target
587.75
587.00
539.70
(8.90%)
Target met
Hold
Broker Report
Strong volume-driven revenue growth, as realisation stays soft 3% YoY due to aggressive push in key markets
29 Apr 2025
ACC
BOB Capital Markets Ltd.
Target
1978.60
2154.00
1892.20
(4.57%)
8.86
Hold
Broker Report
Q4FY25 revenue grew 11% YoY as a strong volume of 14% was offset by 3% fall in realisation, on weak pricing in key operating regions
29 Apr 2025
Greenply Industries
BOB Capital Markets Ltd.
Reco
Target
303.50
345.00
300.95
(0.85%)
13.67
Hold
Broker Report
Beats EBITDA estimate on unexpected sharp improvement in MDF gross margin, despite weak realisations and higher timber prices
29 Apr 2025
Abbott
BOB Capital Markets Ltd.
34365.00
35292.00
30100.00
(14.17%)
Target met
Buy
Broker Report
Novo Nordisk insulin brand outgo to result in 330 bps and 670 bps increase in EBITDA margin to 30.9% and 34.9% for FY26E and FY27E
29 Apr 2025
UltraTech Cement
BOB Capital Markets Ltd.
Target
12523.00
13919.00
11869.00
(5.51%)
11.15
Buy
Broker Report
Healthy 10% YoY volume growth aids flat top line despite 10% dent in realisations in a challenging Q4; capacity utilisation spikes at ~90%
29 Apr 2025
Firstsource Solutions
BOB Capital Markets Ltd.
Reco
Target
351.00
379.00
351.70
(-0.20%)
Target met
Hold
Broker Report
4QFY25 came in at the upper end of guidance. 15.6% YoY CC revenue organic growth in FY25 top quadrant performance
29 Apr 2025
TVS Motor Company
BOB Capital Markets Ltd.
Target
2776.00
2738.00
2702.60
(2.72%)
Target met
Hold
Broker Report
Q4 revenue grew in double digits at 17%/5% YoY/QoQ) to Rs 95.5bn, backed by volume growth of 16% YoY (flat QoQ) to ~1.22mn units
28 Apr 2025
IDFC First Bank
BOB Capital Markets Ltd.
Target
76.14
79.00
66.50
(14.50%)
3.76
Buy
Broker Report
PAT beat estimates, aided by higher non-interest income and lower operating expenses
27 Apr 2025
DCB Bank
BOB Capital Markets Ltd.
Target
143.00
160.00
127.03
(12.57%)
11.89
Buy
Broker Report
Business growth remains strong with a rising focus towards high-yielding advances
25 Apr 2025
Laurus Labs
BOB Capital Markets Ltd.
Reco
Target
818.50
641.00
625.65
(30.82%)
Target met
Hold
Broker Report
Revenue/EBITDA/PAT exceeded our estimates by 8.4%/32.6%/110.3%; EBITDA margin surpassed our estimate by 440 bps